key: cord-0702757-t1ntcrpf authors: Zhu, Ruixuan; Shi, Yaqian; Tan, Yixin; Xiao, Rong title: ACE2 expression on the keratinocytes and SARS-CoV-2 percutaneous transmission, are they related? date: 2020-10-15 journal: J Invest Dermatol DOI: 10.1016/j.jid.2020.09.019 sha: 4ab058c8253d5858836b16a78b3ac7a12a41ed7d doc_id: 702757 cord_uid: t1ntcrpf nan Abbreviations: ACE2, angiotensin converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome-coronavirus 2; COVID-19, Corona Virus Disease 2019; scRNA-seq, single cell RNA sequencing Human angiotensin converting enzyme 2 (ACE2) is an important cell receptor for coronavirus entry into cell. ACE2 is ubiquitously expressed among human tissues. Previous studies have shown that ACE2 was highly expressed in the small intestine, testis, heart and kidney, moderately in lungs, colon, liver and skin, and least expressed in the blood, spleen and bone marrow . The skin, the respiratory track, and the digestive track are the borders between the human body and the external environment, and they are vulnerable to the virus infection because of the expression of ACE2. In the Journal of Investigative Dermatology，Xue et al. (2020) utilized scRNA-seq to examine the expression of ACE2 in skin tissues, and confirmed that the ACE2 was mainly expressed in keratinocytes, which might provide possible routes for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) to invade human cells. Their findings provide a novel insight on the potential transmission route through skin. Previous study shown that the virus can survive on the surface for several days (van Doremalen et al., 2020) and the viral RNA has been detected in stool and urine samples from patients whom were diagnosed with SARS and Corona Virus Disease 2019 (COVID-19) (Cheung et al., 2020) . Besides, rising summer temperature means less clothing and an increased risk of skin exposure to the virus in the environment. These may increase the risk of skin contact with the virus and the virus invading the body through skin damage. However, J o u r n a l P r e -p r o o f whether there is percutaneous transmission is still unknown. COVID-19 skin manifestations were first reported in Guan's study, 0.18% of patients diagnosed with COVID-19 showed a skin rash (Guan et al., 2020) . Another Italian study reported that 20.4% of 88 diagnosed patients developed multiple types of cutaneous manifestations, including erythematous rashes, widespread urticaria and chickenpox-like vesicles (Recalcati., 2020) . However, SARS-CoV-2 polymerase chain reaction (PCR) results were negative on skin lesion biopsies from diagnosed patients with skin manifestation (Ahouach et al., 2020) . Likewise, ACE2 is also abundantly expressed in testis . What's more, despite the presence of significant testicular parenchymal damage in COVID-19 male patients, no virus was detected in testis and semen samples (Pan et al., 2020 , Yang et al., 2020 , Holtmann et al., 2020 . These evidences suggest that direct infection of the virus is unlikely to be the cause of cutaneous and testicular manifestations in COVID-19, the pathological changes in skin and testis are probably nonspecific reaction of COVID-19. The skin barrier defends diverse external disturbance and the human innate immune system protects the body from the invasion of pathologic microorganism (Handfield et al., 2018) . Cutaneous innate immunity is the first line of immune defense which restricts the virus dispersing from the skin and activates adaptive immune response. Meanwhile, intrinsic immunity provides an immediate and direct antiviral defense mediated by host intrinsic restriction factors. On the other hand, host intrinsic immunity is immediately triggered and mediates antiviral defense action. In order to detect the invading viruses, skin cells express a variety of pattern-recognition receptors, such as Toll-like receptors (TLRs) and C-type lectin J o u r n a l P r e -p r o o f receptors (CLRs) (Kawamura et al., 2014) . In Xiao's study (Xiao et al., 2017) , they have found that the fomite transmission route of SARS played a negligible role when working alone, but has a much more effect when working in combination with the airborne transmission. Furthermore, there is no clinical evidence on skin-to-skin infection so far. These evidences imply that the coronavirus cannot infect skin solely through skin contact, and that skin immunity may play an important role in protecting our body from the coronavirus infection. The spike glycoprotein (S protein) on the SARS-CoV-2 surface is bound to the peptidase domain of angiotensin-converting enzyme 2 (ACE2), another protein transmembrane protease serine 2 (TMPRSS2) primes the S protein-related viral entry, but the amino acid transporter B 0 AT1 (also known as SLC6A19) may act as a regulatory factor by blocking ACE2 cleavage to suppress SARS-CoV-2 infection (Yan et al., 2020) . ACE2 expression is more widely distributed than B 0 AT1 (Yan et al., 2020) , which may explain that some of the ACE2 expressing organs, such as lung and heart, are attacked by SARS-CoV-2, while others are not. Apart from ACE2, there may be another way for SARS-CoV-2 to infect host cells. ACE2 is scarcely present in immune cells. However, most SARS patients and COVID-19 patients have lymphopenia, some patients may even have spleen and lymph nodes necrosis (Hamming et al., 2004) . Similarly, ACE2 was absent in platelets but SARS-CoV-2 was detected in platelets from COVID-19 patients (Manne et al., 2020) . These studies suggest that platelets and immune cells may take-up SARS-COV-2 mRNA independent of ACE2. In summary, the work of Xue et al. (2020) provides a new perspective on the potential J o u r n a l P r e -p r o o f percutaneous transmission of COVID-19. But so far, to the clinical data we summarized, no definitive evidence had shown that there is a transmission of COVID-19 through the skin, especially due to the difference of ACE2 expression. Anyhow, we should still attach importance to this potential transmission route due to that human coronavirus are RNA virus with high mutation potential. No datasets were generated or analyzed during the current study. The authors state no conflict of interest. Cutaneous lesions in a patient with COVID-19: are they related? Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from a Hong Kong Cohort: Systematic Review and Meta-analysis China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis Assessment of SARS-CoV-2 in human semen-a cohort study Innate Antiviral Immunity in the Skin Innate and intrinsic antiviral immunity in skin Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Platelet Gene Expression and Function in COVID-19 Patients No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019 Cutaneous manifestations in COVID-19: a first perspective Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2 Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2